Thomas W. Beetham - 03 Mar 2025 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRDN	Stock Option (Right to Buy)	Award	$0	+225,814		$0.000000	225,814	03 Mar 2025	Common Stock	225,814	$14.41	Direct	F1
transaction	VRDN	Restricted Stock Units	Award	$0	+37,636		$0.000000	37,636	03 Mar 2025	Common Stock	37,636		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 3, 2025.
F2	Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.
F3	The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date.